Advanced Search
Contact | Corporate | Help

News Archive of Health News - Fox Business

ArticleAdded
Employers Grateful for Proposed Tax Breaks, But Still Scared09-13-11
Employers Grateful for Proposed Tax Breaks, Still Scared09-13-11
Insmed Shares Drop as FDA Halts Study After Rat Test Results08-02-11
Week Ahead: A Flood Of 2Q Earnings07-15-11
Pfizer Drug Raises Heart Attack Risk: Study07-05-11
FDA Warns Some Prostate Drugs May Worsen Cancer Risk06-10-11
FDA Warns Some Prostate Drugs Could Cause More Severe Cancer06-10-11
Sanofi, Regeneron Cancer Drug Posts Optimistic Results06-06-11
Bristol-Myers, Roche Partner on Melanoma Cure06-02-11
Optimer Diarrhea Drug Gets FDA Approval05-31-11
J&J Talks Pharmaceuticals With Investors05-26-11
Amgen's Xgeva Closer to European Approval05-20-11
Amgen Snags European Recommendation for Bone Drug Approval05-20-11
Pfizer Breaks Barriers with New Lung Cancer Drug05-17-11
Stryker Scoops Up Rival Orthovita for $316M05-16-11
Teva Buys 57% Stake in Japananese Generic Drug Maker05-16-11
JNJ Reserves $1B to Settle Off-Label Case: WSJ05-13-11
Prestige Brands Doubles 4Q Profit on OTC Sales05-12-11
Teva Quarterly Profit Trumps Street As Global Demand Soars05-11-11
Medtronic Scoops Up GE Healthcare's Ishrak05-11-11
Inspire Pharma Narrows 1Q Loss, Cheers Merck Deal05-10-11
Cigna 1Q Profit Impresses on Higher Membership and Fees, Raises View05-05-11
Week Ahead: April Jobs Report and Car Sales04-29-11
Tornado Damages Estimated at $2B to $5B: Analyst04-29-11
Global Sales Push Bristol-Myers' 1Q Profit Ahead of Estimates04-28-11
Pharmasset Shares Plunge on Weak 2Q Performance04-25-11
Week Ahead: Historic Fed Press Conference, Earnings04-22-11
Amgen 1Q Profit Eases, But Adjusted EPS Tops Views04-20-11
Quest Diagnostics Sees 10% Slide in 1Q Profit Amid Bad Weather, Costs04-20-11
Abbott Laboratories 1Q Profit Slumps on Costs04-20-11
Inflation, Debt Fears Push Gold to Record High04-19-11
Novartis Lifts 1Q Profit on New Products04-19-11
S&P Debt Warning Timed to Prod Reform: Analysts04-18-11
Amedisys Scoops Up Beacon Hospice for $125M04-18-11
Report: Johnson & Johnson in Takeover Talks With Synthes04-15-11
Watson Seeks to Market Generic Vigamox; Alcon Files Suit04-08-11
Abbott Labs Heart Device Effective After 2 Years04-04-11
Vertex Treatment Safe in Hepatitis C Clinical Study03-31-11
Experimental Amgen Drug Failed to Improve Survival in Lung Cancer Patients03-30-11
J&J Recalling Thousands of Tylenol Bottles03-30-11
Vertex Cystic Fibrosis Drug Succeeds in Child Study03-29-11
Week Ahead: March Jobs Report, Car Sales and IPOs03-25-11
Week Ahead: February Jobs Report, Car Sales and IPOs03-25-11
JNJ Recalls Medical Drainage Products on Sterility Issues03-25-11
Merck Returning Rights to Stroke Drug to Partner Portola03-24-11
Gilead Sciences Offering $1 Billion in Notes Due 202103-24-11
JNJ to Commercialize Pozen Migraine Drug in South America03-23-11
Sanofi-Aventis, Merck End Animal Health Venture After One Year03-22-11
Celera Shares Jump on Quest Diagnostics $657M Takeover Bid03-18-11
Maxygen Shares Soar on Joint Venture Buyout03-17-11
Lilly's Animal Health Unit to Buy J&J's European Division03-14-11
Salix Fails to Get FDA Approval for Irritable Bowel Syndrome Drug03-08-11
Hospira Appoints Allergen's Mike Ball as CEO03-08-11
Myriad Genetics to Buy Back $50M of its Shares from J.P. Morgan03-02-11
Novavax Awarded $179M Contract by U.S. Govt. to Develop Flu Vaccines03-01-11
Week Ahead: February Unemployment and Car Sales02-25-11
Tenet Healthcare 4Q Profit Beats Wall Street02-25-11
Gilead Science to Acquire Calistoga for $375M to Boost Oncology Unit02-22-11
Medtronic Cuts 2011 Guidance, Slashes 2,000 Jobs02-22-11
MedcoHealth Profit Rises in 4Q, But Still Disappoints02-22-11
Cerus Postpones Feb. 22 Earnings Release02-18-11
Healthways Shares Jump On Higher Sales Outlook02-16-11
Moody's May Upgrade Genzyme On Sanofi Deal02-16-11
Discovery Shares Implode On Stock Offer Pricing02-16-11
Tengion's Stock Crashes On Failed Merger Talks02-16-11
Sanofi Needs To Avoid Pitfalls Of Past Pharma-Biotech Deals02-16-11
Celgene To Buy Back $1 Billion More Stock02-16-11
Structure Of Sanofi's Genzyme Deal Is Rare02-16-11
Genzyme 4Q Profit Soars As Sales, Margins Improve02-16-11
European Stocks Edge Up; Sanofi-Aventis Rallies02-16-11
AstraZeneca Buys 0.7 Million In Own Shares02-16-11
Nobel Biocare Appoints Former Nestle Manager To CEO Post02-16-11
Sanofi To Buy Genzyme For $74 Per Share Plus CVR02-16-11
CSL 1st Half Profit Falls On FX, Loss Of Swine Flu Sales02-16-11
Roche Starts Study Of Subcutaneous Formulation Of MabThera02-16-11
Synthes Posts Strong 2010 Results, Sees Challenging Market In 201102-16-11
DOJ: Two Admit Guilt In Conspiring To Commit Insider Trading02-16-11
Thermo Fisher Again Extends Dionex Tender Offer With 52% Tendered02-16-11
Boston Scientific Buys 2 Devices To Treat Artery Blockages02-15-11
J&J Recalls 70,000 Syringes Of Invega Sustenna Due To Cracks02-15-11
Mannkind Jumps 11% Ahead Of Investor Presentation02-15-11
Warner Chilcott Sees Fiscal 2011 In-Line With Wall Street's View02-15-11
Sanofi To Buy Genzyme For About $74/share: Report02-15-11
Obama Digs In For Tough Negotiations Over Budget02-15-11
FDA Warns Steris On Promotion Of Some Sterilization Products02-15-11
Depomed Falls 8% On FDA Setback02-15-11
Watson Pharmaceuticals Profit Dips, Revenue Up02-15-11
Watson Pharmaceuticals 4Q Profit Falls 68% On Charges02-15-11
Sanofi-Aventis: To Withdraw Anzemet From Five Countries02-15-11
AstraZeneca Buys Back 500,000 Shares For Cancellation02-15-11
Icahn Reports Higher Stake In Motorola02-15-11
Buffett's Berkshire Sells Bank of America, Nike, Fiserv02-15-11
Tepper's Appaloosa Management Boosts Bets On Banks02-14-11
Buffett's Berkshire Sells Bank of America, Nike, Nestle -Filing02-14-11
Mannkind Falls 8% Amid Funding Concerns02-14-11
Deutsche Telekom's Kerkhoff To Join ThyssenKrupp As CFO02-14-11
Deutsche Telekom Says Kerkhoff To Join ThyssenKrupp As CFO02-14-11
Obama Budget To Target Spending, Cut Programs02-14-11
Office of Fair Trading Merger Update02-14-11
OFT Will Not Refer Glaxosmithkline Acquisition Of Maxinutrition02-14-11
AstraZeneca Buys Back 700,000 Shares At 3018P/Share02-14-11
India GlaxoSmithKline Pharmaceuticals 4Q Net Profit Rises 12%02-14-11
Biogen Reports 8.1% Stake In Aveo Pharma02-11-11
FDA Approves Thermo Fisher Kidney Rejection Drug Test02-11-11
Medicaid Insurers Still See Growth Despite State Budget Woes02-11-11
GlaxoSmithKline Buys 0.9 Million In Own Shares02-11-11
FDA Takes Close Look At All-Metal Hips Amid Concerns02-11-11
Orthovita Soars On FDA Okay For Bone-graft Product02-11-11
Cambrex Rockets On Earnings Report02-11-11
GlaxoSmithKline: Kenya To Introduce GSK's Pneumococcal Vaccine02-11-11
BioCryst Shares Climb On Drug Update02-11-11
Mannkind Sinks On Mass Layoff News02-11-11
Cephalon Gets Subpoena From US Postal Service About Fentora02-11-11
Shire To Assess Juvista Data Before Deciding On Action02-11-11
Renovo Plunges As Juvista Fails In Clinical Trial02-11-11
Goldman Sachs Reports 6.8% Stake In Genzyme02-10-11
Cephalon 4Q Down 3%, Adjusted Results Rise; Lifts Fiscal Year View02-10-11
Orthovita Gets FDA Clearance For Vitoss Product, Shares Jump02-10-11
J&J's Cordis Unit Reducing Size Of US Sales Force02-10-11
LabCorp 4Q Profit Narrows Despite Higher Revenues02-10-11
L'Oreal Profit Jumps 25%; Sees Sales, Profit Growth In '1102-10-11
INTERVIEW: Pharma's Painful Changes To Trigger More M&A02-10-11
Crucell Can Resume Quinvaxem Sales, WHO Says02-10-11
GlaxoSmithKline Buys 1.3M Shares To Be Held In Treasury02-10-11
Basilea Attracts Drug Partnership Interest Amid Hopes Of Sale02-10-11
Idenix Plunges On Drug Program Update02-10-11
Shire Net Rises 20%, Sees Rare Drugs Boosting Sales02-10-11
Shire 4Q Profit Dips On Rebates, To Increase R&D Spend02-10-11
LabCorp 4Q Profit Off 7.6% On Higher Tax Provision; View Weak02-10-11
Novartis Drugs Duo Show Promise, To Help Offset Patent Hit02-10-11
Smith & Nephew's Results Beat Forecasts, CEO To Retire02-10-11
Crucell Large Shareholders Plan To Tender Their Stakes To J&J02-10-11
MARKET TALK: Smith & Nephew 4Q Better Than Expected-Guardian02-10-11
Smith & Nephew Names Olivier Bohuon Chief Executive02-10-11
Smith & Nephew 4Q Beats Forecasts, Upgrades Dividend 10%02-10-11
Orexigen Makes Work-Force Cuts After Contrave Rejection02-09-11
BlackRock To Provide Data Requested By Merck For Vytorin Defense02-09-11
Crucell Shareholder Van Herk To Tender Shares To J&J Offer02-09-11
Becton Dickinson Stops Some Forex Hedging, Citing Distraction02-09-11
Neuralstem Soars On FDA Move02-09-11
GlaxoSmithKline Buys 1.48 Million In Own Shares02-09-11
World Heart To Refine Heart Pump, Halts Study Enrollment02-09-11
FDA Gives Neuralstem's Experimental ALS Treatment Orphan Status02-09-11
Sanofi Still In Talks With Genzyme, Sees Lower 2011 Earnings02-09-11
Medtronic To Appeal Court's Affirmation Of $74 Million Award To Rival02-09-11
Medtronic To Appeal Court's Affirmation Of $74 Million Award To Edwards Lifesciences02-08-11
Global Capital Buys 80% Stake In Turkish Medical Company02-09-11
Sanofi Still Talking To Genzyme, Sees Lower 2011 Earnings02-09-11
Elan, Boehringer Ingelheim Inks Development And Manufacturing Pact02-09-11
Sanofi Profit Falls, 2011 Earnings Seen Lower02-09-11
Synta Rallies As Drug Stocks Slip02-09-11
World Heart Pump Study Halted For FDA Refinement Review02-09-11
Sanofi, Genzyme Talks Still On; Sees Lower '11 Net02-09-11
Coventry Health 4Q Profit Rises 38%; Issues Weak Year View02-08-11
Coventry Health Care Profit Up 38%02-08-11
Teva Pharma Shares Drop On Weak Outlook02-08-11
Kindred Healthcare to Buy RehabCare02-08-11
Kindred Healthcare To Acquire RehabCare For About $900 Million02-08-11
Roche's Avastin Successful In Late-Stage Ovarian Cancer Trials02-08-11
Centene Shares Jump On Earnings Beat02-08-11
FDA Sends Fresenius Warning Letter On Red Blood Cell Set02-08-11
Greece Pushes On With Health-Care Reform Amid Prolonged Strikes02-08-11
Community Health CEO: 'Very Determined' In Tenet Bid02-08-11
Humana Earns 63 Cents a Share, Lifts '11 Guidance02-07-11
Emergent Agrees To Be Acquired By Universal Hospital Services02-07-11
Sanofi-Genzyme Takeover Talks in Final Stretch02-07-11
GSK Publishes Bliss-52 Phase Lll Study Results For Benlysta In The Lancet02-07-11
Humana 4Q Net Off 57% Amid Higher Expenses; Raises Year EPS View02-07-11
Danaher To Acquire Beckman Coulter For $5.87 Billion02-07-11
Humana 4Q Profit Shrinks on Expenses02-07-11
GSK Revises US Avandia Label To Include New Restrictions On Use02-07-11
Humana 4Q Net Off 57% Amid Higher Expenses; View Raised02-07-11
AstraZeneca Halts Phase III Trial Of Zibotentan02-07-11
AstraZeneca Halts Prostrate Cancer Drug Trial02-07-11
Sanofi-Aventis, Genzyme Boards To Meet-report02-06-11
Bayer: No Decision Yet On Job Cuts At Pharmaceutical Unit02-06-11
Eli Lilly To Base Employee Bonuses Partly On Research Advances02-04-11
U.S. Stocks Rise, Extending Weekly Gains To 2%02-04-11
Week Ahead: Earnings and a Republican Budget02-04-11
Actelion Shrugs Off Investor Criticism, Backs Management02-04-11
Aetna 4Q Profit Up 30%, Dividend Hiked; Strong '11 View02-04-11
Dialysis-Center Operator DaVita To Buy DSI Renal For $690 Million02-04-11
AmerisourceBergen 1Q Profit Rises 6.1% On Higher Revenue02-04-11
Biotech Actelion Gets Lift On Takeover, Shakeup Hopes02-04-11
Aetna 4Q Profit Up 30% As Medical Ratio Falls; Dividend Hiked02-04-11
Nycomed To Acquire Colombian Company Farmacol02-04-11
AstraZeneca Buys 0.8 Million In Own Shares02-04-11
Actelion Confirms Receiving Letter From Elliott Advisors02-04-11
AstraZeneca: US FDA Gives New PDUFA Date For Brilinta02-04-11
New Pfizer, Merck CEOs Take Different Tacks On Research Costs02-03-11
GlaxoSmithKline 4Q Earnings Fall 30%02-03-11
Consolidated Summary Of January Retail-Sales Results02-03-11
Derma Sciences Shares Rocket On Drug Study02-03-11
Cigna 4Q Profit Rises 40% Amid Light-Demand Trend02-03-11
CVS Caremark Sales, Profits Fall As Pharma Benefits Still Lag02-03-11
Lanxess Names Bernhard Duettmann To Be CFO02-03-11
Walgreen Same-Store Sales Rose 6.1% In January, Top Estimates02-03-11
Merck CEO: Vorapaxar Setback 'Raises Questions About The Compound'02-03-11
Merck Swings To 4Q Loss On Charges; Issues Weak Outlook02-03-11
GlaxoSmithKline Swings To Loss, Plans Buy-back02-03-11
CareFusion To Sell International Surgical Products Unit For $130 Million02-03-11
GlaxoSmithKline, Theravance Reach 2 Milestones In Clinical Development02-03-11
Merck Swings To 4Q Loss On Charges; Issues Weak Fiscal-Year View02-03-11
Cardinal Health Net Off; Adjusted Profit Up02-03-11
Hansen Makes Licensing Pacts With Philips, May Get Up To $107 Million02-03-11
CVS Caremark 4Q Profit Falls 2.2% On Pharma Benefits Weakness02-03-11
Cardinal Health 2Q Profit Down 8.1%, Results Top Street02-03-11
Cigna Posts 40% Increase In Quarterly Net Income02-03-11
Cigna 4Q Profit Rises 40% Amid Stronger Revenue, Investment Gains02-03-11
Shionogi-ViiV Starts Phase III For Fixed-Dose Combination HIV Therapy02-03-11
Takeda Pharmaceutical 9Mos Group Net Profit Y215.49 Billion, Down 16.8% On Year02-03-11
Health-law Repeal Fails In Senate02-02-11
Edwards 4Q Profit Up 36% With Help From Valves02-02-11
US Senate Fails To Approve Repeal Of Health-Care Law02-02-11
Scrushy: Ruling Against Him Will Hurt Alabama Businesses02-02-11
Hospira Now Sees Delayed Cancer Drug Approval At Quarter End02-02-11
Thermo Fisher 4Q Profit Rises 8.9% Amid Stronger Margins02-02-11
Roche Curbs Avastin Outlook On FDA Decision, Strong Franc02-02-11
European Stocks Open Higher; BBVA Falls02-02-11
GlaxoSmithKline Sells Stake In Quest For $1.7 Bln02-02-11
Ipsen Posts Revenue Growth But Taspoglutide Partnership Fails02-02-11
Roche Disappoints As Revamp Costs, Reforms Weigh02-02-11
Roche 2010 Net Profit Misses Views As Revamp Costs Weigh02-02-11
GlaxoSmithKline Sells Entire 30.76 Million Quest Diagnostic Stake For $1.7 Billion02-02-11
Roche 2010 Net Profit Up 4% at CHF8.89Bln, Sales Drop 3%02-02-11
Sanofi-Aventis: Positive Lixisenatide Phase III Results02-02-11
BG Medicine IPO Returns At Half Size, With Fewer Shares Available02-01-11
GlaxoSmithKline Confirms Sale Of Quest Diagnostics Stake02-01-11
Boston Scientific Swings To 4Q Profit On Year-Ago Charge02-01-11
Boston Scientific Swings To Profit02-01-11
New Analysis Suggests Higher Rate Of Fatal Events With Avastin And Chemotherapy02-01-11
Orexigen, Takeda Diet Drug Rejected By FDA02-01-11
Diet Drug Decision Shows Why Drug Makers Have Kept Distance02-01-11
Pfizer Realigns Strategy As Generic Rivals Loom02-01-11
Pfizer To Buy Back Stock, Raise Dividend02-01-11
Pfizer CEO: To Cut R&D Expenses To $6.5 Billion-$7 Billion In 201202-01-11
Pfizer To Close UK R&D Center As Part Of Global Revamp02-01-11
CareFusion Names ResMed Executive As Chairman, CEO02-01-11
Pfizer 4Q Net Triples; Outlook Is Cautious02-01-11
Pfizer 4Q Profit More Than Triples Amid Higher Revenue, Tax Impact02-01-11
Pfizer Reports Higher Fourth-quarter Profit02-01-11
Orexigen Shares Crushed By FDA Rejection02-01-11
Biogen 4Q Profit Drops 21% On Restructuring Costs02-01-11
EARNINGS PREVIEW: Glaxo 4Q Net Loss Of GBP290 Million Seen02-01-11
Health Net Swings To 4Q Profit But Revenue Slides02-01-11
Orexigen,Takeda Diet Drug Rejected By FDA, Data Needed02-01-11
Biogen Adjusted Profit Tops Expectations02-01-11
Orexigen, Takeda Diet Drug Rejected By FDA, Needs More Study02-01-11
Lower Tax Rate Boosts Covidien Profit02-01-11
AstraZeneca's Nasal Flu Vaccine Approved In Europe02-01-11
AstraZeneca: EC Approves Nasal Spray Vaccine Fluenz For Children02-01-11
Imperial Innovations Says Circassia Completes Allergy Trial02-01-11
Quest Diagnostics Plans Buyback, Raises Outlook01-31-11
CR Bard Sees 1Q EPS Of $1.43 To $1.4701-31-11
Epocrates Enacts Stock Split Ahead Of IPO01-31-11
McKesson Earnings Drop On Litigation Charge01-31-11
McKesson Profit Falls On Charge But Co Boosts Full-Year View01-31-11
McKesson 3Q Profit Slides on Weaker H1N1 Season, But Forecast Raised01-31-11
CR Bard 4Q Profit Climbs 29%, Helped By Better Revenue01-31-11
Judge Strikes Down Obama's Health-Care Law01-31-11
Judge Rules Health Law Violates Constitution: WSJ01-31-11
UPDATE: Allergan To Help Sell Map Pharma's Migraine Treatment01-31-11
Genzyme And Sanofi Nearing Deal: Report01-31-11
Genzyme Allows Sanofi-Aventis To Do Due Diligence01-31-11
Czech Health Care Negotiations Break Down, Exodus Possible01-31-11
Judge May Escalate Battle Over Health Care Reform01-31-11
Allergan To Help Sell Map Pharma's Migraine Treatment01-31-11
Sanofi, Genzyme In Due Diligence Pact, Talks Go On01-31-11
Orexigen Shares Jump Ahead Of FDA Decision01-31-11
Pall Jumps 10% As Analyst Eyes Takeover Scenario01-31-11
Depomed Rockets 30% On FDA Approval01-31-11
Sanofi, Genzyme Sign Confidentiality Pact, Talks Ongoing01-31-11
NPS Shares Soar On Favorable Drug Study01-31-11
Allergan To Pay Map Pharma $60 Million To Co-Promote Levadex01-31-11
Anadarko: Gulf Project Production Delayed By Unfit Equipment01-31-11
Genzyme Opens Books to Sanofi in Merger Talks01-31-11
Sanofi, Genzyme Sign Confidentiality Pact As M&A Talks Continue01-31-11
Glaxo Settles Federal Avandia Drug Case Before Going To Trial01-31-11
EARNINGS PREVIEW: Novo Nordisk 4Q Net Profit Seen +79%01-31-11
Dr Reddy's Gets US Court OK To Sell Generic Allegra D-2401-31-11
Dr. Reddy's Laboratories Gets U.S. Court OK To Sell Generic Allegra D-2401-31-11
Daiichi Sankyo Oct-Dec Group Net Profit Up 34% At Y27.5 Billion01-31-11
Pfizer Ordered To Pay $142 Million Over Neurontin Marketing -Bloomberg01-28-11
J&J Loses Stent Case, Set To Pay $482 Million01-28-11
J&J Loses Stent Case, Set To Pay $482 Million Under Verdict01-28-11
Insurer Clarifies Policy, Seen As Win For Spinal Device Makers01-28-11
Week Ahead: January Job Numbers and Earnings01-28-11
Obama: Time For Fighting Health-Care Overhaul Has Passed01-28-11
KKR Said To Drop Out Of Beckman Coulter Bid Group -Bloomberg01-28-11
Obama: Time For Fighting Health-Care Overhaul Has 'Passed'01-28-11
Sanofi Breast Cancer Drug Disappoints in Phase III Trial01-28-11
Boston Scientific:US Suit Shouldn't Have Major Financial Impact01-28-11
DOJ Suing Boston Scientific Over Guidant Recall01-28-11
Bayer Pharma Teams Up With Cadila To Gain Footing In India01-28-11
Takeover Talk Boosts Actelion After Drug Disappoints01-28-11
Swiss Firms Upbeat On Dealmaking; Fincls The Exception -Study01-28-11
Sanofi-Aventis Falls After Breast Cancer Drug Setback01-28-11
Sanofi-Aventis Shares Fall After Breast Cancer Drug Setback01-28-11
Sanofi-Aventis Drops After Cancer Drug Setback01-28-11
Europe Stocks Lower As Miners, Sanofi Fall01-28-11
Sleeping Pill Discontinuation Latest Blow For Actelion01-28-11
Obama Suggests US Should Be Able To Negotiate Drug Prices01-28-11
US Justice Department Files Civil Lawsuit Over Guidant Defibrillators01-27-11
Zimmer 4Q Hit By Spine Charge, But Sales Improve01-27-11
Baxter's Fourth-Quarter Profit Falls 26% On Charges01-27-11
Celgene 4Q Profit Drops 16% Charges As Revenue Jumps01-27-11
Zimmer 4Q Hit By Spinal-Product Charge; Sales Improve01-27-11
Baxter Gets FDA Warning Letter On Puerto Rico Facilities01-27-11
Rite Aid Same-Store Sales Up 1.1% In January01-27-11
Zimmer Holdings 4Q Profit Off 78% On Spine Operations Write-Down01-27-11
Baxter International 4Q Profit Falls 26% On Charges, Weaker Margins01-27-11
Eli Lilly 4Q Profit Jumps 28% On Better Revenue, Margins01-27-11
INTERVIEW: Novartis CEO Optimistic For 201101-27-11
Czech Government Discussing Plan To Prevent Doctors Exodus01-27-11
Novartis Warns Of Tough 2011 But Sees Growth01-27-11
AstraZeneca Buys Back 260,755 Shares At 3066P/Share01-27-11
Novartis's Quarterly Earnings Miss Views, Outlook Cautious01-27-11
Essilor Buys Stakes In 8 Cos In Brazil, South Africa, India, US01-27-11
Operating Room Gear Maker Covidien To Join S&P 500 Index01-26-11
Shoppers Drug CEO Departs Suddenly; Global Search Launched01-26-11
Amgen Considers Dividend As Investors Push For Payment01-26-11
St. Jude Shares Slide with 4Q Profit01-26-11
Abbott Labs 4Q Profit Climbs 10%, Shares Slip on Outlook01-26-11
McKesson CEO Has Been Shedding Rising Shares Via Preset Plan01-26-11
Abbott To Cut 2% Of Work Force, 4Q Net Falls 6.4%01-26-11
St Jude 4Q Profit Up 8.9%; More R&D Spending Planned01-26-11
FDA: Possible Association Between Breast Implants, Rare Cancer01-26-11
WellPoint 4Q Profit Falls 80% Absent Prior-Year Gain01-26-11
Dutch Court Rules Glaxo's Seretide Combination Patent Invalid01-26-11
Abbott Net Income Falls 6%, Adjusted Net Hits Mark01-26-11
St. Jude Medical Profit Tops Estimate01-26-11
Wellpoint Earns $1.40 Per Share, Sales Slips 3.9%01-26-11
Obama Proposes 5-Year Domestic Spending Freeze, Pushes for Investments in Education01-26-11
Obama Challenges Republicans on Cuts, Spending01-26-11
Gilead Net Off 22%; FDA Seeks More HIV-drug Data01-25-11
Plavix Gets Extension On U.S. Market Exclusivity01-25-11
Allegra To Be Sold Over-the-counter01-25-11
Health, Tech Stocks Most At Risk Of Budget Freeze01-25-11
Canadian Stocks Down On Dip For Commodities01-25-11
BioSante Rallies On FDA Move For Melanoma Vaccine01-25-11
J&J 4Q Sales Disappoint on Over-The-Counter Recalls01-25-11
Quest Diagnostics Earnings Per Share Steady01-25-11
3M Fourth-quarter Profit Falls 1%01-25-11
J&J Sales Disappoint, Recalls Hit Consumer Brands01-25-11
Amgen To Buy BioVex For $425 Mln In Cash01-24-11
Amgen Fourth-Quarter Profit Rises 17%01-24-11
Amgen Posts $1 Billion Profit In Fourth Quarter01-24-11
Sanofi Extends Genzyme Bid Again as Talks Continue01-24-11
Clinical Data Leads Drug Stocks North01-24-11
Novartis To Buy Genoptix In $470 Million Deal01-24-11
Week Ahead: Earnings and State of the Union01-21-11
Hospira Will Indefinitely Halt Production of Lethal Injection Drug01-21-11
Intuitive Surgical 4Q Profit Climbs 55% on da Vinci System01-21-11
Acorda, Biogen Fall On EU Drug Rejection01-21-11
Intuitive Surgical Shares Jump 14% On Earnings01-21-11
Immelt Sees No Conflicts In White House Posting01-21-11
Vivus Shares Tumble On Diet Drug Update01-21-11
GE Sees Flat To 5% Revenue Growth For 201101-21-11
AstraZeneca Responds To FDA On Ticagrelor01-21-11
GE Quarter Exceeded Expectations At Morningstar01-21-11
EMA: CHMP To Review Baxter Peritoneal Dialysis Solutions Manufacture01-21-11
Boehringer Ingelheim: Japan Oks Prazaxa For Stroke Prevention01-21-11
AstraZeneca Responds To US FDA CRL For Brilinta01-21-11
Merck KGaA: CHMP Confirms Negative Opinion On Cladribine For MS01-21-11
S&P Upgrades Cooper Cos. To Just Below Investment Grade01-20-11
St. Jude Medical To Pay $16 Million To Settle Reimbursement Probe01-20-11
Intuitive Surgical 4Q Profit Up 56% As Sales Surge01-20-11
Biogen: Six More Cases Of Brain Infection In Tysabri Patients01-20-11
FDA Panel: Lilly's Imaging Drug Not Ready For Approval01-20-11
Intuitive Surgical Quarterly Profit Jumps01-20-11
Intuitive Surgical 4Q Profit Up 56% On Robotic Procedure Volume01-20-11
Biogen, Elan Again Boost Prices Of MS Treatments01-20-11
Pfizer, Other Drug Companies Want Patent Docs Kept Secret01-20-11
Pfizer, 36 Other Drug Companies Want Patent Documents Kept Secret01-20-11
UnitedHealth Profit Rises On Light Medical Claims01-20-11
Denmark's Zealand Pharma Betting On New Diabetes Drugs01-20-11
Drug Indexes Slip As Mannkind Sinks01-20-11
Perrigo Shares Up After Deal To Buy Paddock Labs01-20-11
Mannkind Tanks On FDA Rejection01-20-11
UnitedHealth Profit Rises As Medical Costs Drop01-20-11
UnitedHealth Reports Widened 4Q Profit, Tops Wall Street01-20-11
UnitedHealth Profit in 4Q Tops Views01-20-11
UnitedHealth Group Earns 94 Cents, Affirms Outlook01-20-11
UnitedHealth 4Q Profit Rises 10% As Medical Ratio Improves01-20-11
Dr. Reddy's Launches Generic Heartburn Drug In US01-20-11
France's Sarkozy: Can't Let Health Spending Rise Unchecked01-20-11
Mannkind Shares Plunge After FDA Defers Approval01-19-11
House Votes To Repeal Obama's Health-care Law01-19-11
House Votes 245-189 To Repeal Sweeping Health-Care Law01-19-11
Merck: Increased Bleeding In Stroke Patients Seen In Drug Studies01-19-11
House Votes to Repeal Health-Care Overhaul01-19-11
US Supreme Court Questions Pricing Lawsuit Against Drug Makers01-19-11
Mannkind Slides Ahead Of FDA Decision01-19-11
Boston Scientific to Pay $375M for Atritech01-19-11
Depomed Tumbles; Drug Indexes Split01-19-11
Boston Scientific To Acquire Medical Device Maker Atritech01-19-11
Siemens Could Soon Take Over HearUSA01-19-11
Roche Pipeline Gets Lift After Strong Skin Cancer Data01-19-11
Glaxo, Prosensa Starts Phase III Of Duchenne Medication Dystrophy01-19-11
House Tones Down Health-Care Debate After Shooting01-19-11
Glaxo Tests Intravenous Flu Drug Against Roche's Tamiflu01-19-11
GlaxoSmithKline Starts Phase III Study Of Intravenous Zanamivir01-19-11
Roche Pipeline Gets Lift After Strong RG7204 Skin Cancer Data01-19-11
OJSC Pharmstandard Acquisition of 55% stake in Biolek (Ukraine)01-19-11
Glenmark: Unit Gets FDA OK To Sell Generic Malaria Drug01-19-11
Merck KGaA: Survival Benefit From Erbitux-Folfox Confirmed01-19-11
Depomed Shares Slide On Commercialization Dispute With Abbott01-18-11
Pharmasset Files To Offer Three Million Shares01-18-11
NuVasive Says Cigna, Humana Back Spine Procedure; Shares Rise01-18-11
US Supreme Court Questions Barring Of Suit Over Bayer Cholesterol Drug01-18-11
FDA: Lilly Beta-Amyloid Imaging Drug Works, But Benefit Unclear01-18-11
Medtronic Alters Key US Study For New Heart Valves01-18-11
Forest Laboratories 3Q Profit Up on Improved Drug Sales01-18-11
Pluristem Jumps On Stem Cell Therapy Update01-18-11
Medtronic Alters US Study For New Heart Valves01-18-11
Alexza Shares Tumble On FDA Setback01-18-11
LONDON MARKETS: Burberry, ARM Holdings Boost London Index01-18-11
CVS Names Interim Heads For Retail Business01-18-11
Theater of the Absurd from Jintao and Obama01-18-11
Aria Rockets On Cancer Drug Data01-18-11
Proposed Lilly Beta-Amyloid Imaging Drug Works, But Benefit Not Clear01-18-11
LONDON MARKETS: Burberry, ARM Holdings And Miners Boost London01-18-11
Forest Laboratories' 3Q Net Up 53% As Drug Sales Rise01-18-11
FDA: Proposed Lilly Beta-Amyloid Imaging Drug Works, Seems Safe01-18-11
Ariad Shares Rally On Positive Results For Cancer Drug01-18-11
LONDON MARKETS: Burberry, SABMiller And Miners Boost London01-18-11
LONDON MARKETS: Burberry, SABMiller Lead London Stocks Higher01-18-11
RBS Sells Priory Group In $1.47 Billion Deal01-18-11
AstraZeneca Buys 267,831 In Own Shares01-18-11
Futura Medical: CE Authority Raises Minor Points For CSD500 Condom01-18-11
Bayer, Regeneron To Begin Phase III Trial For VEGF Trap-Eye01-18-11
EU Asks Pharma Cos For Info On Patent Agreements01-17-11
LONDON MARKETS: Banks Weigh On London As Smiths Group Jumps01-17-11
EU Asks Pharma Cos For More Info On Patent Settlements01-17-11
Glaxo To Take GBP2.2 Billion Legal Charge In 4Q On Drug Litigation01-17-11
GlaxoSmithKline Expects To Record 4Q Legal Charge Of GBP2.2 Billion01-17-11
Smiths Group Rejection Of Bid For Unit Revives Breakup Talk01-17-11
Abbott Withdraws Marketing Authorization Application For Ozespa01-17-11
EU Asks Some Pharma Companies More Info On Patent Settlements01-17-11
LONDON MARKETS: BP, Smiths Group Rise In Steady U.K. Market01-17-11
Smiths Medical: To Set Up Wholly-Owned Unit In India01-17-11
Smiths Group Shares Soar After It Gets Approach01-17-11
Smith & Nephew Shares Jump Again On Newspaper Takeover Report01-17-11
Roche Names Hippe As CFO To Succeed Hunziker01-17-11
Glenmark: Disappointed With US Jury Decision On Tarka Patent Case01-17-11
Intel Will Invest $500 Million In Leixlip, Ireland, Plant01-15-11
J&J Recalling More Over-The-Counter Drugs01-14-11
J&J to Recall More Over-The-Counter Drugs01-14-11
J&J Recalls More Over-The-Counter Medicines For Quality01-14-11
Johnson & Johnson Recalls More Over-The-Counter Meds On Quality Issues01-14-11
California Blue Shield Agrees To Outside Rate-Increase Review01-14-11
Community Health Bid For Tenet Healthcare Grows More Hostile01-14-11
Community Health Nominates Full Slate For Tenet's Board01-14-11
Smiths Rejects Apax GBP2.45 Billion Offer For Smiths Medical01-14-11
Smiths Rejects Apax's GBP2.45 Billion Cash Offer For Smiths Medical01-14-11
Community Health To Make Tenet Board Nominations01-14-11
Two Patients On Sanofi's Multaq Have Liver Failure01-14-11
LONDON MARKETS: Miners Drag London To Lower Close01-14-11
Cumberland Rallies As Drug Indexes Hug Flat Line01-14-11
Bristol-Myers, Sanofi Recall Hypertension Drug01-14-11
Abbott Withdraws US, European Applications For Psoriasis Drug01-14-11
Thermo Fisher Extends Tender Offer For Dionex Amid Weak Response01-14-11
Sanofi-Aventis: Position Has Not Changed On Genzyme01-14-11
Sanofi: 2 Patients Treated With Multaq Suffer Liver Failure01-14-11
Sanofi-Aventis Hopes to Win Genzyme for $76 a Share01-14-11
Smith & Nephew Denies In M&A Talks, Shares Fall01-14-11
Smith & Nephew: Not Engaged In Deal Talks01-14-11
Boehringer Ingelheim Agrees To Sell Resomer To Evonik01-14-11
LONDON MARKETS: Miners' Weakness Weighs On London Shares01-14-11
Smith & Nephew Plc Statement regarding press speculation01-14-11
Smith & Nephew Not Engaged In Merger Talks01-14-11
Lupin: Unit Gets FDA OK To Sell Generic Osteoarthritis Drug01-14-11
Cumberland Pharma Shares Rally On Acetadote's FDA Approval01-13-11
BOND REPORT: Treasurys Rise With Jobless Claims, Auctions' End01-13-11
FDA Approves Life Tech Kit That Detects Egg Salmonella Faster01-13-11
BOND REPORT: Treasurys Lifted By Fed Buys; 30-year Sale In Line01-13-11
US House To Vote On Repeal Of Health-Care Law Next Week01-13-11
Merck Stops Blood Clot Prevention Study, Shares Tumble01-13-11
BOND REPORT: Treasurys Rise After Fed Purchases01-13-11
Crucell Resumes Operations At South Korean Vaccine Plant01-13-11
BioCryst Falls On Study Delay For Flu Drug01-13-11
Merck Tumbles On Drug Study Woes01-13-11
Blood Pressure Study Reflects Well On Novartis's Tekamlo01-13-11
Roche CEO: Group Well Positioned, Drug Innovation Top Focus01-13-11
French Essilor Buys 50% Stake In China's Lenses Maker Wanxin01-13-11
FDA Panel Recommends Nonapproval Of Lilly Therapy Liprotamase01-12-11
FDA Panel Rejects Lilly Pancreatic-Enzyme Replacement01-12-11
FDA Panel: Lilly Pancreatic-Enzyme Replacement Drug Doesn't Seem Effective01-12-11
US Judge Accepts $296 Million Government-Guidant Plea Deal01-12-11
Human Genome Sciences CEO Cautions On Lupus Drug Launch01-12-11
Europe Clears Sanofi-Aventis' Purchase Of Genzyme01-12-11
Biogen R&D Head Seeks To Return Company To Biotech Roots01-12-11
Watson Pharmaceuticals BAcks Fiscal 2010 Estimates01-12-11
Merck, Parexel Team Up to Develop Biosimilars01-12-11
U.S. Attorney Sues New York City Over Medicaid01-11-11
Eli Lilly, Private Pharmacy to Develop Diabetes Molecules01-11-11
U.S. Attorney Sues New York City for Medicaid Fraud01-11-11
Genzyme, Sanofi-Aventis Discuss Values for Multiple Sclerosis Drug01-10-11
Health-Care Repeal Clears Hurdle in House01-07-11
Anacor Jumps On Analyst Rating01-07-11

SourceSolution © 2008-2012